Clinical and cost effectiveness of a parent mediated intervention to reduce challenging behaviour in pre-schoolers with moderate to severe intellectual disability (EPICC-ID) study protocol: a multi-centre, parallel-group randomised controlled trial by Farris O et al.
STUDY PROTOCOL Open Access
Clinical and cost effectiveness of a parent
mediated intervention to reduce
challenging behaviour in pre-schoolers
with moderate to severe intellectual
disability (EPICC-ID) study protocol: a multi-
centre, parallel-group randomised
controlled trial
Olayinka Farris1, Rachel Royston1* , Michael Absoud2, Gareth Ambler3, Jacqueline Barnes4, Rachael Hunter5,
Marinos Kyriakopoulos6, Kate Oulton7, Eleni Paliokosta8, Monica Panca5, Laura Paulauskaite1, Michaela Poppe1,
Federico Ricciardi3, Aditya Sharma9, Vicky Slonims2, Una Summerson10, Alastair Sutcliffe11, Megan Thomas12 and
Angela Hassiotis1
Abstract
Background: Children with intellectual disabilities are likely to present with challenging behaviour. Parent mediated
interventions have shown utility in influencing child behaviour, although there is a paucity of UK research into
challenging behaviour interventions in this population. NICE guidelines favour Stepping Stones Triple P (SSTP) as a
challenging behaviour intervention and this trial aims to evaluate its clinical and cost effectiveness in preschool
children with moderate to severe intellectual disabilities.
Methods: This trial launched in 2017 at four sites across England, with the aim of recruiting 258 participants (aged
30–59 months). The Intervention Group receive nine weeks of SSTP parenting therapy (six group sessions and three
individualised face to face or telephone sessions) in addition to Treatment as Usual, whilst the Treatment as Usual
only group receive other available services in each location. Both study groups undergo the study measurements at
baseline and at four and twelve months. Outcome measures include parent reports and structured observations of
behaviour. Service use and health related quality of life data will also be collected to carry out a cost effectiveness
and utility evaluation.
Discussion: Findings from this study will inform policy regarding interventions for challenging behaviour in young
children with moderate to severe intellectual disabilities.
Trial registration number: Clinicaltrials.gov, NCT03086876. Registered 22nd March 2017, https://clinicaltrials.gov/
ct2/show/NCT03086876.
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Background
Intellectual Disability (ID) is a lifelong condition charac-
terized by limitations in cognitive ability and adaptive
behaviours identifiable from early childhood [1]. A re-
port by the Challenging Behaviour Foundation in 2014
estimated that approximately 10,000 children with ID in
the UK show challenging behaviour [2]. Challenging be-
haviour is defined as actions of such intensity, frequency
and duration that it threatens the physical safety of a
person or others around them [3]. Behaviours include
self-injury, physical aggression and non-person directed
behaviour such as property destruction [4]. Whilst chal-
lenging behaviour is reported to persist over time, only a
small percentage of participants receive intervention [5].
Early intervention has been particularly influential in
the improvement of longer term outcomes in children
with conduct or behavioural disorders [6–11]. Health
Economists have also demonstrated the cost benefit of
interventions experienced in the preschool years, given
that the early years are the time of maximum brain de-
velopment, and also of maximum malleability [12–16].
Einfeld and colleagues [17] showed that challenging
behaviour increases care costs, which may be prevented
with affordable early intervention programmes.
Despite promising evidence from a number of parent
mediated interventions with children in the general popu-
lation (e.g. Sure Start, Video Feedback Sensitive Discipline,
and Triple P- Positive Parenting Programme) [18], there is
a paucity of UK based early intervention research for re-
ducing challenging behaviours in young children with ID.
Most existing interventions have been developed for chil-
dren with behavioural problems with no specificity to ID.
NICE guidelines (advised by the parent members of
the guideline development group) indicated that parent-
ing interventions particularly Stepping Stones Triple P
(SSTP), an adapted version of Triple P (TP), demon-
strate sufficient evidence in reducing challenging behav-
iour in children with ID [19]. TP (and SSTP) is a system
of psycho-educational and behavioural approaches that
aim to increase parental confidence and skills so that
parents are able to manage the child’s behaviour effect-
ively. SSTP comprises different levels depending on in-
creasing family complexity, with Level 4 recommended
for parents of children with severe behavioural problems.
Efficacy trials outside the UK have indicated significant
reductions in challenging behaviour in children with ID
[20]. Although there is a scarcity of economic data for
SSTP itself, trial and observational data from a number
of countries suggest delivery of TP may be cost-effective,
especially if it were applied at population levels [21, 22].
Aims
This study aims to evaluate the clinical and cost effect-
iveness of Level 4 SSTP in a multi-site parallel cluster
randomised control trial of preschool children with
moderate to severe ID 12months post randomisation.
Treatment as usual (TAU) is available to participants in
both arms of the trial.
The primary hypothesis is that the addition of level 4
SSTP to TAU will reduce challenging behaviour on
completion of the intervention at 12 months post ran-
domisation, compared to TAU alone. The primary out-
come is the severity of challenging behaviour using the
parent completed preschool Child Behaviour CheckList
(CBCL) [23].
The secondary hypotheses include:
 SSTP will reduce challenging behaviour measured at
12 months post randomisation in blind rated
observations and caregiver/teacher questionnaire
measures.
 SSTP will be more cost-effective compared to TAU.
Method
Trial design and setting
The randomised control trial is parallel and two-armed
with blinding of outcome assessors. It includes a process
evaluation with parent qualitative interviews to enhance
understanding of the appropriateness and feasibility of the
intervention. The study was planned and implemented in
accordance with the Consolidated Standards of Reporting
Trials (CONSORT) extension standards to compare the
cost-effectiveness of the combination of SSTP plus TAU,
versus TAU alone in reducing challenging behaviour at
12months post randomisation. The trial design is sum-
marised in Fig. 1.
Study participants are recruited from a wide variety of
services within the participating centres in North and South
London, North East (Newcastle and surrounding areas) and
North West England (Blackpool and surrounding areas).
Services include NHS settings, e.g. Child Development
Teams; Child and Adolescent Mental Health Services; edu-
cation (nursery/preschool) and third sector organisations
e.g. caregiver groups. A number of Participant Identification
Centres have also been opened (Table 1).
Eligibility criteria
Parents of young children concerned about their child’s
behaviour within the four participating centres are eli-
gible for inclusion in the study if:
1. Parents are at least 18 years of age.
2. Child is aged 30–59months at identification.
3. Child has moderate to severe ID (parent reported
Adaptive Behaviour Assessment System (ABAS)
General Adaptive Functioning score of 40–69) [24].
4. Reports of challenging behaviour over a 6- month
period but no less than 2 months.
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Fig. 1 Flow chart of the study design. This chart demonstrates the flow of participants through the trial from initial contact to the completion of
the follow-up assessments
Table 1 List of recruitment sites and participant identification centres
Site Participant Identification Centres (PICs)
Blackpool Teaching Hospitals NHS Foundation Trust None
Central and North West London NHS Foundation Trust Royal Free London NHS Foundation Trust
Imperial College Healthcare NHS Trust
Great Ormond Street Hospital NHS Foundation Trust
Primary Care (Islington/Camden GP practices, Barnet
CCG practices, Enfield CCG practices)
Guy's and St Thomas' NHS Foundation Trust St George’s University Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
Cumbria, Northumberland, Tyne and Wear NHS
Foundation Trust
Northumbria Healthcare NHS Foundation Trust
South Tyneside and Sunderland NHS Foundation Trust
Newcastle upon Tyne Hospitals NHS Foundation Trust
Gateshead NHS Foundation Trust
Note: CCG Clinical Commissioning Groups
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Exclusion Criteria
1. Child has mild, profound or no ID on parent
reported ABAS.
2. Parent/carer has insufficient English language to
complete study questionnaires.
3. Another sibling is taking part in the study.
Participant identification and screening
Eligible participants are identified by the community
paediatric and child and adolescent mental health teams
in each of the four areas. Health or social care profes-
sionals identify eligible participants through new refer-
rals or existing cases. Identification involves reviewing or
screening identifiable personal information of partici-
pants by members of the regular clinical team. A mem-
ber of clinical staff/clinical study officer contacts eligible
participants, gives an introduction to the study and the
study Patient Information Sheet. All participants who
are interested in taking part complete an Expression of
Interest form which is then passed on to the researchers.
Parents need to consent to the screening process, in-
cluding the parent administered ABAS about the child’s
adaptive behaviour/level of functioning. This determines
whether a child’s level of intellectual ability falls within
the inclusion criteria, and confirms that the child has
had challenging behaviours continually in the past two
months, i.e. such behaviours being present several times
a week. Where the child fulfils the adaptive function
range, the baseline assessment (assuming consent is given)
takes place following which the participant is randomised
either to the intervention arm (SSTP plus TAU) or TAU.
Interventions
SSTP plus TAU Level 4 Stepping Stones Triple P is a 9
week psycho-education programme with 6 group sessions
and three individual telephone or face to face contact with
participants. SSTP is an adapted parenting programme for
children with ID. The sessions cover strategies that par-
ents can use to reduce unwanted behaviours, maintain
behavioural change, cultivate a positive relationship with
their child and facilitate independent problem solving.
Each group session lasts approximately 2.5 h and individ-
ual sessions last about 30min. Parents receive a course
book with topics to be covered in each session and are
contacted by the therapist if a session is missed.
Treatment fidelity Each therapist (eight: two per centre)
responsible for delivering SSTP has been trained in the
Stepping Stones Training and Accreditation programme.
Therapists were observed by TP trainers to build therap-
ist competence and are provided with monthly supervi-
sion to ensure fidelity of the intervention and ongoing
support and skills maintenance as is appropriate for
psychosocial interventions [25]. Further, to determine
whether treatment was delivered as intended (adher-
ence), each therapist completes individual session check-
lists and all the sessions are videotaped to be rated by
independent assessors (competence). A random 10% of
assessments is double rated for reliability by an external
blinded expert. Therapist deviations from the manua-
lised intervention will be recorded to examine where
flexibility may be required based on individual partici-
pant needs.
Treatment as usual Parents continue to access inter-
ventions and therapies on offer to them in their local
area, including a range of services such as support from
health visitors, primary care engagement and advice,
early intervention provided by community paediatric ser-
vices or Child and Adolescent Mental Health Services,
and parenting advice and support sessions by carers’
groups or other third sector organisations. It includes
evidence based treatments (e.g. Webster Stratton Incred-
ible Years, Early Bird and Strengthening Families inter-
ventions), support groups by third sector and voluntary
groups (e.g. the charity Contact and locally organised
parent groups) and via the NHS, which provides psycho-
logical and behavioural therapies as part of professional
care (please see Additional File 1 for a more comprehen-
sive list of available interventions). Parents allocated to
both arms of the trial also receive a list of national re-
sources and the Contact guide to challenging behaviour
with tips and advice on social and health care supports.
Outcome measures
Outcomes are measured by self-report, direct parent-
child observations and face-to-face interviews (See
Table 2 for list of measures). All participants are
assessed at the following time points: screening (T1),
baseline (T2), four months post-randomisation (T3)
and 12 months post-randomisation (T4). The assess-
ment window for follow-ups is four weeks. Data col-
lected outside these time windows will be recorded
but not used for the main analyses (see Table 3 for the
schedule of assessments at each time point).
The primary outcome measure is the parent com-
pleted Child Behaviour Checklist (CBCL; 24) at 12
months. The CBCL is a robust and widely used ques-
tionnaire which measures child behaviour and has been
previously used in clinical trials and epidemiological
studies of children with ID [36, 37]. Secondary outcomes
include direct observations of parent-child interactions,
parental health, stress and competence, service use and
health related quality of life (Table 2).
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Sample size
A sample of 258 children (SSTP: 155 children, TAU: 103
children) will allow us to detect a low to moderate (standar-
dised) effect size of 0.40 for the primary outcome at the 5%
significance level, with 90% power. This is equivalent to
detecting a clinically meaningful difference between the
two treatment groups of 8 points, assuming a standard de-
viation of 20. This calculation is based on baseline-adjusted
(ANCOVA) analysis assuming a correlation of 0.5 between
baseline and follow-up measurements. In addition, the cal-
culation has been adjusted for therapist clustering, assum-
ing an intra-class correlation of 0.05, average group size of
7, and an anticipated drop-out of 10%.
Recruitment
It was estimated that 22 months would be needed to
recruit the total sample of 258 at a recruitment rate of
12 children per month. Such rates are similar to other
studies of children with neurodisability [38]. Data from
the participating sites suggest they receive in excess of
100 referrals a year (and as many as 300), at least a third
of whom could be eligible for the study. Therefore, re-
cruitment of the required number of participants within
this age range was deemed feasible. A multisource refer-
ral strategy is being followed, facilitated by the clinical
research networks, national, clinical and third sector
contacts, as well as social media. Participants receive £15
vouchers at each assessment time point for time donated
to the study. In addition, child care and travel for partic-
ipants may also be reimbursed where appropriate.
Methods – assignment of interventions
Allocation
Participants are randomised using a 3:2 allocation ratio
to either SSTP or TAU using randomly permuted blocks
of varying block sizes and stratification by site and level
Table 2 List of study outcome measures
Outcome Measure details
Primary outcome measure: Child Behaviour
Checklist (CBCL)
Each question relates to a specific behaviour and is measured on a 3-point Likert Scale. Overall scores
are derived for behavioural difficulties, attention problems and aggression. A T-score of Total Problem
Behaviours of 60 or over signifies borderline to clinical caseness. CBCL incorporates DSM-5 diagnostic
categories which rate comorbidities, e.g. autism spectrum disorders, mood disorders.
Mullen Scales of Early Learning Assesses child level of disability [26]. Only assessed during the baseline assessment.
Revised Family Observation Schedule
(FOS-RIII)
FOS-RIII is an objective measure of parent-child interaction, previously used in studies investigating
SSTP and codes 20 min (four 5-min consecutive sections) home based videotaped parent-child interactions
[27]. There will be an inter-rater reliability exercise on a proportion of the observations to ensure
reliability.
Child Behaviour Checklist Caregiver-Teacher
Report Forms (C-TRF)
Most children in the sample age range will have additional care outside the parental home allowing
us to have additional perspectives on the child’s behaviour. The CBCL and C-TRF are extensively used
to measure child’s behaviour and there are positive reports about high completion rates by teachers/
nursery staff as shown in other studies [28].
General Health Questionnaire (GHQ) Common psychiatric morbidity in the parent will be assessed at baseline, 4-month and 12-month
follow-up.
Questionnaire on Resources and Stress
(QRS-F short form)
Measures parental stress in caregivers of chronically ill or children with ID at baseline, 4-month and
12-month follow-up [29].
Caregiving Problem Checklist-Difficult Child
Behaviour
The frequency of difficult child behaviour when the parent is completing care-giving tasks will be
measured at baseline, 4-month and 12-month follow-up. Internal consistency is adequate (α = .78) [30].
Parenting Sense of Competence Scale
(PSOC)
Assesses Satisfaction and Efficacy competencies as a parent at baseline, 4-month and 12-month
follow-up [31]. Internal consistency for the measure ranges from α = .70–.80 [31].
Child and Adolescent Service Use Schedule
(CA-SUS)
A modified version will be used in the trial to assess child health and social care service use at
baseline, 4-month and 12-month follow-up [32].
Paediatric Quality of Life (PedsQL) Assesses health related quality of life. The measure covers Physical, Emotional, Social, and School
Functioning domains. It contains a parent proxy report for children aged 2 years and over and will be
used in the study to derive Quality-Adjusted Life Year (QALYS) for the health economic evaluation.
Internal consistency for the parent version is acceptable (α = .86) and has demonstrat4ed discriminant
validity. This will be completed at baseline, 4-month and 12-month follow-up [33].
EuroQol-5D Captures parental and caregiver perspective on their health status at baseline, 4-month and 12-month
follow-up which will be used in the economic evaluation [34].
Client Satisfaction Questionnaire Measures parent intervention acceptability [35]. The questionnaire will allow parents to provide
feedback about the intervention during the 4 month follow-up by commenting on their satisfaction
with and experience of the intervention, including ease of use, format and helpfulness. It has been
specifically developed for research in SSTP and has high internal consistency (α = .92) [30].
Case Report Forms (CRF) To collect sociodemographic and clinical information about comorbidities.
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of ID (moderate and severe). Randomisation and data
management is provided by Sealed Envelope [39], a com-
mercial clinical randomisation and data management web
service.
Allocation concealment and implementation
Research assistants enter baseline assessment results on a
web-based case report form (CRF). Each case is assigned a
study number and parents and therapists are given infor-
mation about allocation status. Arrangements are then
made to commence the group sessions. Researchers are in
separate departments than staff involved in delivery of
level 4 SSTP. The therapists do not treat any families allo-
cated to TAU.
Blinding
Although it is not possible to blind trial participants
or therapists delivering the intervention, parents are
reminded not to disclose any details about their treat-
ment to the research team during assessments. Re-
search assistants and the lead statistician remain blind
to trial arm allocation, with the lead statistician not
attending the closed part of the Data Safety and Moni-
toring Board (DSMB) meeting. Any violations of the
study protocol are recorded and reported to the Trial
Steering Committee and the DSMB.
Data collection methods
All data are collected and handled in accordance with
PRIMENT Standard Operating Procedures (SOPs). A
unique identification number is assigned to each partici-
pant and all identifying participant information is stored
separately and securely in UCL Data Safe Haven, a
secure system for storing sensitive study information.
Source data verification checks will be completed on
100% of the primary outcome measure, as well as for 5%
of all secondary outcome measures. The delegation log
identifies all those personnel with responsibilities for
data collection and handling, including those who have
access to the trial database.
Long-term experience of studies with people with ID
suggests that very few are lost to follow up (e.g. PBS
study, TIME-A study). Participants may still wish to
meet with the researchers but not take part in interven-
tions. Therefore, although we shall stress that partici-
pants can withdraw at any time without giving a reason,
we shall retain any assessment records that have been
carried out to that point and we shall maintain contact
unless told otherwise.
Data management
Audio and video recordings are stored on Data Safe
Haven and are deleted from the digital machines from
Table 3 Schedule of assessments
Visit no 1 2 3 4
Tasks Screening Baseline assessment* 4 month follow-up 12month follow-up
Allowed deviation window n/a +/ week +/− 4 weeks +/− 4 weeks
Informed consent (screening) x
Assessment of eligibility criteria x x
Adaptive Behaviour Assessment Schedule (< 69) x
Research assessments minimum 1week, maximum 4 weeks
after screening)
Informed consent (research) x
Mullen Scales of Early Learning x
CRF x
Preschool CBCL x x x
Parent-child observation and FOS-RIII x x x
C-TRF x x x
GHQ-12 x x x
QRS-F short form x x x
Caregiving Problem Checklist-Difficult Child Behaviour scale x x x
PSOC x x x
CA-SUS x x x
Client Satisfaction Questionnaire x
Peds-QL x x x
EQ-5D x x x
*: at baseline, all assessments will be carried out prior to randomisation
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which they were originally recorded. The CRFs are
entered into a web-based clinical data management
system, Red Pill, provided by Sealed Envelope through
PRIMENT. Original copies of outcome measures are
stored in locked cabinets in a locked office. At the end
of the trial, prior to analysis, PRIMENT SOP Database
Lock, Unlock and Closure will be followed. All aspects
of data management of the study comply with the UK
Data Protection Act 1998, PRIMENT SOPs, GDPR and
Good Clinical Practice.
Patient and public involvement
Parents of children with ID and challenging behaviour
from the Camden Special Needs Forum assisted in the
development of the study proposal. Four parent members
of the national charity CONTACT were also recruited to
form the Parent Advisory Group (PAG), meeting four
times annually to assist in overseeing the trial, discussing
study progress and helping with materials. The PAG will
be involved with reviewing the full study report and dis-
semination plan.
Process evaluation
To understand how psychosocial interventions work in
practice, particularly due to the paucity of SSTP delivery
within the UK NHS, a process evaluation utilising a
mixed methods approach has been included within the
trial. This includes assessment of what is delivered (fidel-
ity, dose, adaptations, reach), collection of the opinions
of a stratified purposive stakeholder sample, i.e. partici-
pants (those in the intervention/TAU groups, as well as
those who have declined, approximately 10–12 from
each); 6–8 service managers; and all therapists. Parents
participating in these qualitative interviews receive an
additional £15 voucher. Therapists also ask parents in
the intervention arm to complete a brief satisfaction
questionnaire to assess satisfaction with the intervention
at the end of the final group session.
Statistical methods
Analysis of primary outcome
A consort flow diagram [40] is used to describe the pro-
gress of participants through the study and the follow-
up at different time points. Descriptive analyses (means,
standard deviations, relevant quantiles and proportions)
will be used to summarise the characteristics of the chil-
dren in each study arm. A comparison of baseline char-
acteristics will be performed to assess whether balance
has been achieved; any notable imbalances may lead to
additional adjusted analyses for continuous outcomes.
The primary analysis of the CBCL score at 12 months
will use mixed models to perform an individual level
analysis and will follow Roberts and Roberts (2005) [41]
in adjusting for therapist clustering in the intervention
arm only (random coefficient model). The final model will
also adjust for baseline CBCL score and randomization
stratification factors (centre, level of ID) using fixed
effects. All modelling assumptions will be checked and a
sensitivity analysis will be performed relaxing the hetero-
scedasticity assumption. Significance will be considered at
the 5% level and confidence intervals with be at the 95%
level.
Additional analyses will be performed for the second-
ary outcomes. Continuous outcomes will be analysed
using a similar modelling approach to that described for
the primary outcome, but for binary outcomes we shall
use logistic mixed models [42]. The amount of missing
data in each trial arm will be reported and we will investi-
gate its impact on the balance achieved by randomisation.
We will also explore whether missingness is associated
with any participant characteristics, using descriptive com-
parisons and tests as appropriate. This may lead to further
adjusted analyses. Stata 15 and R 3.6.0 or above will be
used to perform the analyses.
Economic evaluation
The economic evaluation will be conducted from a
health and social care perspective in the primary ana-
lysis, and from a societal perspective in a secondary ana-
lysis, which includes the impact on quality of life of
parents and other caregivers contributing to the child’s
care. The Child and Adolescent Service Use Schedule
(CA-SUS) [43] tracks the personal, societal and health
service resource usage in the past 6 months at baseline
and 12-month follow-up and in the past 4 months at 4-
month follow-up. The primary analysis will include only
health and social care data collected as part of the trial,
meaning this will only cover 10 months of the trial
(missing months 4 to 6). Sensitivity analyses will be used
to project costs from the follow-ups to estimate the 12-
month health and social care resource use. UK unit costs
obtained from publicly available sources will be applied
to each resource item in both arms of the trial [44, 45].
Benefits payments will be costed from government
statistics. Data on delivery of the intervention will be
collected to calculate the cost of the intervention using
micro-costing methods [46].
The overall economic evaluation will comprise: 1) Cost-
effectiveness analysis estimating the mean incremental cost
per change in CBCL; 2) Exploratory analysis of quality of
life using the PedsQL to predict utility scores. There is no
single, valid, preference-based measure for health state
valuation in children under the age of 5 or children with
ID and therefore it is not currently possible to calculate
Quality-Adjusted Life Years (QALYs) for use in cost-utility
analysis [47]. Therefore, the PedsOL and the mapped EQ-
5D-Y utility scores algorithm [48, 49] will be utilised to
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calculate QALYs; 3). Cost-benefit analysis of the impact on
the parents/caregivers.
Cost and effect data will be combined to calculate
incremental cost-effectiveness ratios for each analysis.
We shall use non-parametric bootstrap estimation to de-
rive 95% confidence intervals for mean cost and effect
differences between the trial groups and to calculate
95% confidence intervals around the incremental cost-
effectiveness ratios. We will include adjustments for
baseline values (costs, CBCL and effects) in the three
analyses. Cost-effectiveness acceptability curves, showing
the percentage of cases for which, the intervention is
cost-effective will be constructed using the bootstrap
data. A series of sensitivity analyses will be undertaken
to explore the implications of uncertainty on the incre-
mental cost-effectiveness ratios.
Data monitoring
The study is overseen by a Data Safety and Monitoring
Board (DSMB) which has six monthly meetings to manage
trial procedures. Members have no competing interests
and are independent from the study sponsor and orga-
nisers. Interim analyses are supplied to the DSMB which
advise the Trial Steering Committee (TSC) on whether
the active intervention is successful and whether the eco-
nomic outcomes evidence is sufficient to guide recom-
mendations for SSTP to health care providers. No interim
analyses are planned.
Harms
Serious Adverse Events (SAE; untoward occurrences that
result in harm) are reported via the eCRF by the trial
manager within 24 h of becoming aware of the event. All
reports are reviewed by the CI or PIs within 2 days of re-
ceiving the report and the outcome is recorded in the
eCRF. SAEs that are determined to be related and unex-
pected are reported to the ethics committee and to PRI-
MENT, in accordance with the PRIMENT non-clinical trial
of an investigational medicinal product (Non-CTIMP)
safety management SOP.
Auditing
Site visits are conducted at all sites annually. The site
file, consent forms, enrolment and screening logs are
checked and source data verification checks are con-
ducted. A monitoring report is usually compiled and
reviewed by PRIMENT.
Confidentiality
All study-related information is stored securely at the
study site. All participant information is stored in locked
file cabinets in locked rooms with limited access and
data is also stored through the secure online system,
Data Safe Haven. Data is identified by identification
numbers to maintain participant confidentiality. Per-
sonal information is stored separately from the study
records.
Dissemination policy
The study papers will be published in high impact jour-
nals and targeted communications for parents will be
published through the charity Contact. Contact will also
advise on other media and policy opportunities that
allow for dissemination. Findings will be communicated
at local, national and international conferences including
for lay and parent groups. A study report for the funders
will be posted on the HTA website. Parents will be in-
volved at all stages and take part in commenting on re-
ports and papers prior to publication as well as leading
on presentations. In the event of a negative trial, it is im-
portant to know whether treatment as usual as currently
provided in the services in England may be as effective
as a manualised intervention. Therefore, the study, re-
gardless of outcome, will be published and disseminated.
All co-applicants will be listed as authors. The protocol
will be published in an open access journal; the dataset
and statistical codes will be available by sharing agree-
ments upon request.
Department of Health Disclaimer
This report presents independent research commissioned
by the National Institute for Health Research (NIHR). The
views and opinions expressed by authors in this publica-
tion are those of the authors and do not necessarily reflect
those of the NHS, the NIHR, MRC, CCF, NETSCC or the
Department of Health.
Trial status
Participant recruitment in this study commenced in
September 2017. A 10-month internal pilot tested feasi-
bility, acceptability and recruitment at all sites, using the
full baseline and eligibility and follow-up assessment bat-
tery for all cases and the start-up of SSTP delivery to
some of the participants. The progression criterion was
that the rate of recruitment between months 5–14
should be at least 70% of the rate expected (no fewer
than 8 children per month). This was achieved and the
Trial Steering Committee advised NIHR to proceed to
the full trial. The study is actively recruiting. To date,
190 participants have been randomised into the study
and 19 groups have been completed.
Discussion
This paper describes the study protocol for a multicentre
trial designed to investigate the clinical and cost-effectiveness
of a parent mediated intervention (SSTP) to reduce challen-
ging behaviour in pre-schoolers with moderate to severe ID.
Challenging behaviour is prevalent and persistent in children
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with moderate to severe ID and is associated with many
negative outcomes, including later psychiatric morbid-
ity [4, 50–52], poorer quality of life, parental stress and
high service costs [53–56].
SSTP is a parenting programme that has demonstrated
efficacy in non-UK randomised controlled trials to re-
duce challenging behaviour in children and improve
parent outcomes [19, 57, 58]. A recent meta-analysis of
16 studies has highlighted the large evidence base for
Level 4 SSTP, which had the strongest treatment effects
compared to other SSTP levels for improving behaviour
in children with ID [20]. However, the majority of stud-
ies included small sample sizes (mean = 60.2, SD = 43.8)
and randomised control trials of SSTP have not been
conducted in the UK to compare this intervention to
other readily available therapies.
To our knowledge, this is the first UK trial to evaluate
the effectiveness of SSTP as a parent mediated interven-
tion for challenging behaviour in very young children.
The findings will inform real-world practice and NICE
clinical recommendations about the provision of group
interventions for children with moderate to severe ID
[51]. We have already identified significant variability in
available services for this population across the 4 sites in
the UK and therefore, rolling out the intervention should
be underpinned by appropriate evidence.
The study has several strengths, it is multicentre and
is powered to detect a significant difference between
intervention and TAU arms. The primary study outcome
measure (CBCL) is a robust and widely validated meas-
ure of behaviour, which will be further validated through
the use of behavioural observations of challenging be-
haviour at each time point. Additionally, data from
multiple respondents is being collected on the CBCL
(e.g. parents and another caregiver such as a teacher) to
examine accuracy and enable the potential measurement
and comparison of behaviours across different contexts
and with different caregivers. The secondary outcome
measures will also provide critical information on vari-
ables that are known to impact child behaviour [59, 60].
Moreover, conducting a process evaluation and fidelity
testing ensures the external validity of the study and will
examine gaps in the implementation that are likely to
hinder uptake [61].
Limitations include the lack of blinding of participants,
potential attrition of participants and deviations in the
delivery of the intervention. Further, only parents with
sufficient English to respond to the questionnaires and
follow the intervention guidance can be recruited into
the study.
In conclusion, the results of the trial described in this
protocol will provide a vital contribution to intervention
research for reducing challenging behaviour in children
with ID. This population is said to be underserved, with
almost no access to evidence based interventions for
challenging behaviour early in life [62]. The trial will
inform policy on the clinical and cost-effectiveness of
SSTP, with the aim of improving behaviour and out-
comes for children with moderate to severe ID and their
families.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12888-020-2451-6.
Additional file 1. List of known interventions/therapies on offer at
participating sites. This additional file provides a list of examples of some
known interventions/therapies available at participating sites. All
participants in the study (intervention and treatment as usual) can attend
any additional therapies during participation in the study. This list is
indicative of the variety of interventions on offer (as of August 2019) at
participating sites and is not exhaustive.
Abbreviations
ABAS: Adaptive Behaviour Assessment System; CA-SUS: Child and Adolescent
Service Use Schedule; CBCL: Child Behaviour Checklist; CI: Chief Investigator;
CRF: Case Report Form; CTIMP: Clinical Trial of an Investigational Medicinal
Product; C-TRF: Child Behaviour Checklist Caregiver - Teacher Report Forms;
DSM-5: Diagnostic and Statistical Manual of Mental Disorders 5th Edition
American Psychiatric Association; DSMB: Data Safety and Monitoring Board;
EQ-5D: EuroQoL Five Dimensions Scale; FOS: Revised Family Observation
Schedule, FOS-RIII; GCP: Good Clinical Practice; GDPR: General Data
Protection Regulation; GHQ: General Health Questionnaire; GP: General
Practitioner; HRA: Health Research Authority; ID: Intellectual Disability; Main
REC: Main Research Ethics Committee; NHS R&D: National Health Service
Research & Development; NIHR HTA: National Institute for Health Research
Health Technology Assessment Programme; PAG: Parent Advisory Group;
QALYs: Quality-Adjusted Life Years; SOP: Standard Operating Procedure;
SSTP: Stepping Stones Triple P; TAU: Treatment as Usual; Term: Definition;
TMG: Trial Management Group; TP: Triple P; TSC: Trial Steering Committee
Acknowledgements
Not applicable.
Authors’ contributions
AH conceived the study and led the study design with support from co-
applicants (GA, JB, MK, MA, EP, AlS, KO, VS, RH, AdS, US, MT). GA, FR, RH and
MoP developed the statistical and health economic elements of the trial and
will be conducting the relevant analyses; MK is leading on patient and public
involvement; US is representing experts by experiences (families of children
with disabilities) and advising on all trial aspects; KO on process evaluation;
JB is advising on observations and trial methodology; MA, VS, AdS, EP and MT
are site leads and also support implementation of training and therapist
supervision; AlS is supporting implementation in North London; RR, OF, MiP
and LP are data collecting and prepared the manuscript for publication. OF
and RR contributed equally to this work. All authors contributed to
refinement of the study protocol and approved the final manuscript.
Funding
This work is supported by NIHR HTA, grant number: 15/162/02. The protocol
has been peer-reviewed by the funder. This funding source had no role in
the design of this study and will not have any role during its execution,
analyses, interpretation of the data, or decision to submit results.
Availability of data and materials
The datasets generated during the current study are not publicly available as
data collection is ongoing. Data will be available to Principal Investigators on
request once the dataset is clean and locked and the study publications
completed.
Farris et al. BMC Psychiatry           (2020) 20:35 Page 9 of 11
Ethics approval and consent to participate
Informed written consent is obtained from all parents in the study at
screening and baseline by Research Assistants. Children are aged 30–59
months and have a moderate to severe learning disability, therefore consent
is only obtained from parents. The study was approved by the London-
Camden & Kings Cross Research Ethics Committee (reference: 17/LO/0659).
Any proposed amendments are submitted to the REC committee and
approvals cover all sites.
Consent for publication
Not applicable.
Competing interests
The authors declare they have no competing interests.
Author details
1Division of Psychiatry, University College London, 6th Floor Maple House,
149 Tottenham Court Road, London W1T 7NF, UK. 2Evelina London
Children’s Hospital, St Thomas’ Hospital, Westminster Bridge Road, London
SE1 7EH and King’s College London, Strand, London WC2R 2LS, UK.
3Department of Statistical Science, University College London, Gower Street,
London WC1E 6BT, UK. 4Department of Psychological Sciences, Birbeck
University of London, Malet Street, London WC1E 7HX, UK. 5Research
Department of Primary Care and Population Health, Royal Free Medical
School, NW3 2PF, London, UK. 6South London and Maudsley NHS
Foundation Trust and Department of Child and Adolescent Psychiatry,
Institute of Psychiatry, Psychology and Neuroscience, King’s College London,
PO66 De Crespigny Park, London SE5 8AF, UK. 7Great Ormond Street
Hospital for Children NHS Foundation Trust, Great Ormond Street, London
WC1N 3JH, UK. 8The Effra Clinic, 4th Floor, 86-90 Paul Street, London EC2A
4NE, UK. 9Institute of Neuroscience, Newcastle University, Newcastle upon
Tyne NE1 7RU, UK. 10Contact, 209-211 City Road, EC1V 1JN, London, UK.
11Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK.
12Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool Victoria
Hospital, Whinney Heys Road, Blackpool FY3 8NR, UK.
Received: 27 November 2019 Accepted: 21 January 2020
References
1. American Psychiatric Association. Diagnostic and statistical manual of
mental disorders (5th ed.). Arlington, VA; 2013.
2. Emerson E, Hastings RP, McGill P, Pinney A, Shurlock J. Estimating the
number of children in England with learning disabilities and whose
behaviours challenge; 2014.
3. Emerson E, Bromley J. The form and function of challenging behaviours. J
Intellect Disabil Res. 1995;39(5):388–98.
4. Absoud M, Wake H, Ziriat M, Hassiotis A. Managing challenging behaviour
in children with possible learning disability. BMJ. 2019;365:l1663.
5. Einfeld SL, Piccinin AM, Mackinnon A, Hofer SM, Taffe J, Gray KM, Bontempo
DE, Hoffman LR, Parmenter T, Tonge BJ. Psychopathology in young people
with intellectual disability. JAMA. 2006;296(16):1981–9.
6. Scott S, Webster-Stratton C, Spender Q, Doolan M, Jacobs B, Aspland H.
Multicentre controlled trial of parenting groups for childhood antisocial
behaviour in clinical practiceCommentary: nipping conduct problems in the
bud. BMJ. 2001 Jul 28;323(7306):194.
7. Barnes J. Interventions addressing infant mental health problems. Child Soc.
2003;17(5):386–95.
8. Lindsay G, Davies H, Band S et al. Parenting Early Intervention
Pathfinder Evaluation, Department for Children, Schools and Families
Research Report No. DCSF-RW054, Department for Children Schools and
Families, London; 2008.
9. Allen, G. & Duncan-Smith, I. Early intervention: good parents, great kids,
better citizens. London: Centre for Social Justice and Smith Institute; 2008.
Available from: http://www.centreforsocialjustice.org.uk/client/downloads/
EarlyInterventionpaperFINAL.pdf
10. Scott S, Sylva K, Doolan M, Price J, Jacobs B, Crook C, Landau S.
Randomised controlled trial of parent groups for child antisocial
behaviour targeting multiple risk factors: the SPOKES project. J Child
Psychol Psychiatry. 2010 Jan;51(1):48–57.
11. Allen G. Early intervention: the next steps. The Stationery Office; 2011 Jan
20. Available from: https://wwwgovuk/government/uploads/system/
uploads/attachment_data/file/284086/early-intervention-next-steps2pdf
accessed September 2019.
12. Department of Health. Our children deserve better: prevention pays. Annual
Report of the Chief Medical Officer 2012. London; 2012. Available from:
https://www.gov.uk/government/publications/chief-medical-officers-annual-
report-2012-our-children-deserve-better-prevention-pays
13. Heckman JJ. Invest in the very young. Chicago: Ounce of Prevention
Fund; 2000.
14. Cunha F, Heckman JJ. The economics and psychology of inequality and
human development. J Eur Econ Assoc. 2009;7(2–3):320–64.
15. Heckman JJ. Skill formation and the economics of investing in
disadvantaged children. Science. 2006;312(5782):1900–2.
16. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson B. CDBE2010
study group, European brain council. The economic cost of brain disorders
in Europe. Eur J Neurol. 2012 Jan;19(1):155–62.
17. Einfeld SL, Ellis LA, Doran CM, Emerson E, Horstead SK, Madden RH, Tonge
BJ. Behavior problems increase costs of care of children with intellectual
disabilities. J Ment Health Res Intellect Disabil. 2010;3(4):202–9.
18. Axford N, Barlow J, Coad J, Schrader-McMillan A, Sonthalia S, Toft A, Wrigley
Z, Goodwin A, Ohlson C, Bjornstad G. The best start at home: what works to
improve the quality of parent-child interactions from conception to age 5
years? Early Intervention Foundation: A rapid review of interventions; 2015.
19. Whittingham K, Sofronoff K, Sheffield J, Sanders MR. Stepping stones triple
P: an RCT of a parenting program with parents of a child diagnosed with
an autism spectrum disorder. J Abnorm Child Psychol. 2009;37(4):469.
20. Ruane A, Carr A. Systematic review and meta-analysis of stepping
stones triple P for parents of children with disabilities. Fam Process.
2019;58(1):232–46.
21. Foster EM, Prinz RJ, Sanders MR, Shapiro CJ. The costs of a public health
infrastructure for delivering parenting and family support. Child Youth Serv
Rev. 2008;30(5):493–501.
22. Mihalopoulos C, Sanders MR, Turner KM, Murphy-Brennan M, Carter R. Does
the triple P–positive parenting program provide value for money? Aust N Z
J Psychiatry. 2007;41(3):239–46.
23. Achenbach TM, Rescorla LA. Manual for the ASEBA preschool forms and
profiles (Vol. 30). Burlington: University of Vermont; Research center for
children, youth, & families. 2000.
24. Harrison PL, Oakland T. Adaptive behavior assessment system. Encyclopedia
Clin Neuropsychol. 2017:1–4.
25. Cooper C, Mukadam N, Katona C, Lyketsos CG, Ames D, Rabins P, Engedal K,
de Mendonça LC, Blazer D, Teri L, Brodaty H. Systematic review of the
effectiveness of non-pharmacological interventions to improve quality of
life of people with dementia. Int Psychogeriatr. 2012 Jun;24(6):856–70.
26. Mullen EM. Manual for the Mullen scales of early learning. Cranston, RI: T.O.
T.A.L. Child. 2015.
27. Sanders MR, Waugh L, Tully L, Hynes K. The revised family observation
schedule. 3rd ed. Brisbane, Queensland, Australia: Parenting and Family
Support Centre; 1996.
28. Achenbach TM, Rescorla LA. Manual for the ASEBA preschool forms and
profiles (Vol. 30). Burlington, VT: University of Vermont, Research center for
children, youth, & families; 2000.
29. Rousey A, Best S, Blacher J. Mothers' and fathers' perceptions of stress and
coping with children who have severe disabilities. Am J Ment Retard. 1992
Jul;97(1):99–110.
30. Plant KM, Sanders MR. Reducing problem behavior during care-giving in
families of preschool-aged children with developmental disabilities. Res Dev
Disabil. 2007;28(4):362–85.
31. Johnston C, Mash EJ. A measure of parenting satisfaction and efficacy. J Clin
Child Psychol. 1989;18(2):167–75.
32. Byford S, Barrett B, Roberts C, Wilkinson P, Dubicka B, Kelvin RG, White L, Ford C,
Breen S, Goodyer I. Cost-effectiveness of selective serotonin reuptake inhibitors
and routine specialist care with and without cognitive-behavioural therapy in
adolescents with major depression. Br J Psychiatry. 2007;191(6):521–7.
33. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the
pediatric quality of life inventory. Med Care. 1999;37(2):126–39.
34. EuroQoL Group (1990) EuroQoL. A new facility for the measurement of
heath-related quality of life. Health Policy. 1990 Dec;16(3):199–208.
35. Roberts C, Mazzucchelli T, Studman L, Sanders MR. Behavioral family
intervention for children with developmental disabilities and behavioral
Farris et al. BMC Psychiatry           (2020) 20:35 Page 10 of 11
problems. J Clin Child Adolesc Psychol 2006;35(2):180–193. https://doi.org/
10.1207/s15374424jccp3502_2.
36. Dekker MC, Nunn R, Koot HM. Psychometric properties of the revised
developmental behaviour Checklist scales in Dutch children with intellectual
disability. J Intellect Disabil Res. 2002;46(1):61–75.
37. Wallander JL, Dekker MC, Koot HM. Risk factors for psychopathology in
children with intellectual disability: a prospective longitudinal population-
based study. J Intellect Disabil Res. 2006;50(4):259–68.
38. Geretsegger M, Holck U, Gold C. Randomised controlled trial of
improvisational music therapy's effectiveness for children with autism
spectrum disorders (TIME-A): study protocol. BMC Pediatr. 2012;12(1):2.
39. Sealed Envelope Ltd. Simple randomisation service; 2019. Available from:
https://www.sealedenvelope.com/simple-randomiser/v1/.
40. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines
for reporting parallel group randomised trials. BMC Med. 2010;8(1):18.
41. Roberts C, Roberts SA. Design and analysis of clinical trials with clustering
effects due to treatment. Clin Trials. 2005;2(2):152–62.
42. Roberts C, Batistatou E, Roberts SA. Design and analysis of trials with a
partially nested design and a binary outcome measure. Stat Med. 2016;
35(10):1616–36.
43. Byford S, Barrett B, Roberts C, Wilkinson P, Dubicka B, Kelvin RG, White L,
Ford C, Breen S, Goodyer I. Cost-effectiveness of selective serotonin
reuptake inhibitors and routine specialist care with and without cognitive–
behavioural therapy in adolescents with major depression. Br J Psychiatry.
2007;191(6):521–7.
44. Department of Health (2015). NHS reference costs: financial year 2013 to 2014.
45. Curtis LA, Burns A. Unit costs of health and social care 2015. Personal Social
Services Research Unit; 2015.
46. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW.
Methods for the economic evaluation of health care programmes. Oxford
university press; 2015 Sep 25.
47. Bevans KB, Riley AW, Moon J, Forrest CB. Conceptual and methodological
advances in child-reported outcomes measurement. Expert Rev
Pharmacoecon Outcomes Res. 2010;10(4):385–96.
48. Khan KA, Petrou S, Rivero-Arias O, Walters SJ, Boyle SE. Mapping EQ-5D
utility scores from the PedsQL™ generic core scales. Pharmacoeconomics.
2014;32(7):693–706.
49. Viecili MA, Weiss JA. Reliability and validity of the pediatric quality of life
inventory with individuals with intellectual and developmental disabilities.
Am J Intellect Dev Disabil. 2015;120(4):289–301.
50. National Institute for Health and Clinical Excellence (NICE). Autism: the
management and support of children and young people on the autism
spectrum. NICE Clinical Guideline 170. London: NICE; 2013.
51. National Institute for Health and Care Excellence (NICE): Clinical Guideline
[NG11]. Challenging behaviour and learning disabilities: prevention and
interventions for people with learning disabilities whose behaviour
challenges. British Psychological Society/Royal College of Psychiatrists; 2015.
www.nice.org.uk. Accessed 8th September 2019.
52. Scott S, Spender Q, Doolan M, Jacobs B, Aspland H. Multicentre controlled
trial of parenting groups for childhood antisocial behaviour in clinical
practice. BMJ. 2001;323:1–7.
53. Davies LE, Oliver C. Self-injury, aggression and destruction in children with
severe intellectual disability: incidence, persistence and novel, predictive
behavioural risk markers. Res Dev Disabil. 2016 Feb 1;49–50:291–301. https://
doi.org/10.1016/j.ridd.2015.12.003.
54. Knapp M, Comas-Herrera A, Astin J, Beecham J, Pendaries C. Intellectual
disability, challenging behaviour and cost in care accommodation: what are
the links? Health Soc Care Commun. 2005 Jul;13(4):297–306. https://doi.org/
10.1111/j.1365-2524.2005.00539.x.
55. McIntyre LL, Blacher J, Baker BL. Behaviour/mental health problems in
young adults with intellectual disability: the impact on families. J Intellect
Disabil Res. 2002;46(3):239–49.
56. Myrbakk E, Von Tetzchner S. The prevalence of behavior problems among
people with intellectual disability living in community settings. J Ment
Health Res Intellect Disabil. 2008;1(3):205–22.
57. Tellegen CL, Sanders MR. Stepping stones triple P-positive parenting
program for children with disability: a systematic review and meta-analysis.
Res Dev Disabil. 2013;34(5):1556–71.
58. Roux G, Sofronoff K, Sanders M. A randomized controlled trial of group
stepping stones triple P: a mixed-disability trial. Fam Process 2013;52(3):411–
424. https://doi.org/Doi https://doi.org/10.1111/Famp.12016.
59. Totsika V, Hastings RP, Emerson E, Berridge DM, Lancaster GA. Behavior
problems at 5 years of age and maternal mental health in autism and
intellectual disability. J Abnorm Child Psychol. 2011;39(8):1137–47. https://
doi.org/10.1007/s10802-011-9534-2.
60. Totsika V, Hastings RP, Emerson E, Lancaster GA, Berridge DM. A population-
based investigation of behavioural and emotional problems and maternal
mental health: associations with autism spectrum disorder and intellectual
disability. J Child Psychol Psychiatry. 2011;52(1):91–9. https://doi.org/10.1111/
j.1469-7610.2010.02295.
61. Ozbek A, Gencer O, Mustan AT. Which parents dropout from an evidence-
based parenting programme (triple-P) at CAMHS? Comparison of
programme-completing and dropout parents. Clin Child Psychol Psychiatr.
2019;24(1):144–57. https://doi.org/10.1177/1359104518792294.
62. Adams D, Handley L, Simkiss D, Walls E, Jones A, Knapp M, et al.
Service use and access in young children with an intellectual disability
or global developmental delay: associations with challenging behaviour.
J Intellect Dev Disabil 2018;43(2):10:1–10. https://doi.org/10.3109/
13668250.2016.1238448.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Farris et al. BMC Psychiatry           (2020) 20:35 Page 11 of 11
